MetaCap

Azora Therapeutics Quarterly Balance Sheet

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Azora Therapeutics financial position

As of Sep 30, 2026, Azora Therapeutics reported total assets of $22.5 million, up 298.0% from a year earlier against total liabilities of $5.1 million. Shareholders' equity was negative at -$21.1 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $22.0 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 4.43, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Azora Therapeutics balance sheet (quarterly)

Azora Therapeutics quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q2 20242024-03-31Q4 20232023-12-31
Cash & Equivalents22.00M28.71M4.58M5.88M4.61M5.91M2.37M3.75M5.20M3.29M5.03M2.83M
Total Current Assets22.38M28.84M4.80M6.18M5.01M6.08M2.63M4.06M5.62M3.82M—3.20M
Intangible Assets3.00K3.00K2.64K3.00K2.92K3.07K3.21K3.35K3.49K3.63K—3.91K
Total Assets22.53M29.09M5.23M6.67M5.66M6.80M3.45M5.04M6.71M4.95M—4.74M
Accounts Payable1.39M2.62M573.57K655.00K556.28K671.12K532.43K250.13K318.12K316.73K—103.33K
Total Current Liabilities5.06M5.12M1.51M1.40M1.15M1.21M1.32M975.86K829.05K671.88K—653.08K
Total Liabilities5.06M28.93M1.51M1.40M1.15M1.21M1.32M975.86K829.05K671.88K—653.08K
Shareholders' Equity-21.06M-38.38M3.72M5.28M4.50M5.59M2.13M4.07M5.88M4.28M6.12M4.08M
Retained Earnings-208.55M-143.98M-91.99M-89.97M-87.98M-86.18M-84.22M-82.00M-79.92M-77.73M—-68.80M
Net Cash (Debt)22.00M28.71M4.58M5.88M4.61M5.91M2.37M3.75M5.20M3.29M5.03M2.83M
Shares Outstanding2.63M2.63M1.51M1.11M23.84M21.53M6.65M258.83K6.41M4.29M—1.66M

This table shows 12 quarterly periods of Azora Therapeutics's balance sheet, from Q3 2026 back to Q4 2023, across 13 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a balance sheet?

More financial data